US Stock MarketDetailed Quotes

TCON Tracon Pharmaceuticals

Watchlist

0.125
+0.050+66.13%

15min DelayClose Aug 23 16:00 ET

425.14KMarket Cap0.02P/E (TTM)

Tracon Pharmaceuticals Stock Forum

103449386

Aug 2 11:47

$Tracon Pharmaceuticals (TCON.US)$ Please up again

Trytosaveabit

Jul 30 15:50

Oompphh!

$Tracon Pharmaceuticals (TCON.US)$ Reuters· 2 mins ago
TRACON Pharmaceuticals Inc - Announces It Will Wind Down Operations

Emmanuel Padilla

Jul 15 08:37

$Tracon Pharmaceuticals (TCON.US)$ ALL OF A SUDDEN WE HAVE PRE MARKET? WHAT A BUNCH OF MANIPULATIVE BASTARDS

TrendTrader

Jun 14 14:32

Over 1.57 can see 1.7 and 2

$Tracon Pharmaceuticals (TCON.US)$

Abela

Jun 14 14:24

$Tracon Pharmaceuticals (TCON.US)$ I thought they got delisted 🤔🤔🤔🤔

2017x

Jun 12 22:06

$Tracon Pharmaceuticals (TCON.US)$ joke company leave now before too late

Abela

Jun 12 13:25

$Tracon Pharmaceuticals (TCON.US)$ delisted tomorrow get outbefor more drop

SarangArin

Jun 12 08:18

$Tracon Pharmaceuticals (TCON.US)$ why is this falling 50%

Shamell Francis

Jun 12 08:07

$Tracon Pharmaceuticals (TCON.US)$
why is it falling

Jaguar8

Jun 11 07:12

NEWS

$Tracon Pharmaceuticals (TCON.US)$
TRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage Repair Inhibitor, in Recurrent Glioblastoma Patients
TRACON Pharmaceuticals (NASDAQ: TCON) announced the publication of Phase 2 clinical data on its DNA damage repair inhibitor, TRC102, in recurrent glioblastoma patients.
Published in Clinical Cancer Research, the study evaluated TRC102 combined with Temodar in 19 patients who had progression following ...

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

Concept

Top Gainers Yesterday

Intraday-0.22%